NO301763B1 - Eventuelt substituerte pyrido-[2,3-d]-pyrimidin-2,4-(1H,3H)-dioner og pyrido-[2,3-d]pyrimidin-2-(1H,3H)-oner, anvendelse av slike for fremstilling av legemidler, samt farmasöytiske preparater inneholdende slike - Google Patents

Eventuelt substituerte pyrido-[2,3-d]-pyrimidin-2,4-(1H,3H)-dioner og pyrido-[2,3-d]pyrimidin-2-(1H,3H)-oner, anvendelse av slike for fremstilling av legemidler, samt farmasöytiske preparater inneholdende slike

Info

Publication number
NO301763B1
NO301763B1 NO943456A NO943456A NO301763B1 NO 301763 B1 NO301763 B1 NO 301763B1 NO 943456 A NO943456 A NO 943456A NO 943456 A NO943456 A NO 943456A NO 301763 B1 NO301763 B1 NO 301763B1
Authority
NO
Norway
Prior art keywords
pyrimidine
pyrido
dione
pharmaceuticals
ones
Prior art date
Application number
NO943456A
Other languages
English (en)
Norwegian (no)
Other versions
NO943456L (no
NO943456D0 (no
Inventor
Robert S Wilhelm
Ronnie L Chin
Bruce H Devens
Robert Alvarez
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO943456L publication Critical patent/NO943456L/no
Publication of NO943456D0 publication Critical patent/NO943456D0/no
Publication of NO301763B1 publication Critical patent/NO301763B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO943456A 1992-03-20 1994-09-16 Eventuelt substituerte pyrido-[2,3-d]-pyrimidin-2,4-(1H,3H)-dioner og pyrido-[2,3-d]pyrimidin-2-(1H,3H)-oner, anvendelse av slike for fremstilling av legemidler, samt farmasöytiske preparater inneholdende slike NO301763B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/855,179 US5264437A (en) 1992-03-20 1992-03-20 Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
PCT/US1993/002273 WO1993019068A1 (en) 1992-03-20 1993-03-18 PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS

Publications (3)

Publication Number Publication Date
NO943456L NO943456L (no) 1994-09-16
NO943456D0 NO943456D0 (no) 1994-09-16
NO301763B1 true NO301763B1 (no) 1997-12-08

Family

ID=25320543

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943456A NO301763B1 (no) 1992-03-20 1994-09-16 Eventuelt substituerte pyrido-[2,3-d]-pyrimidin-2,4-(1H,3H)-dioner og pyrido-[2,3-d]pyrimidin-2-(1H,3H)-oner, anvendelse av slike for fremstilling av legemidler, samt farmasöytiske preparater inneholdende slike

Country Status (16)

Country Link
US (1) US5264437A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP1770093A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3241384B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100274104B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1040327C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU669520B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2132297C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI106960B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HUT67552A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL105092A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9301530A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO301763B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ251525A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW240226B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1993019068A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA931945B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672622A (en) * 1994-04-21 1997-09-30 Berlex Laboratories, Inc. Treatment of multiple sclerosis
US6060501A (en) * 1994-06-02 2000-05-09 Schering Aktiengesellschaft Combined treatment of multiple sclerosis
US5817670A (en) * 1994-08-29 1998-10-06 Yamanouchi Pharmaceutical Co., Ltd. Naphthyridine derivatives and pharmaceutical compositions thereof
WO1996024350A1 (de) * 1995-02-10 1996-08-15 Schering Aktiengesellschaft Pharmazeutische präparate zur tnf-inhibition
DE19540475A1 (de) * 1995-10-20 1997-04-24 Schering Ag Chirale Methylphenyloxazolidinone
NZ322197A (en) * 1995-11-21 1999-02-25 Yamanouchi Pharma Co Ltd Pyrido[2,3-d] pyrimidine derivatives and pharmaceutical compositions thereof
JP2000119272A (ja) 1998-10-15 2000-04-25 Nippon Zoki Pharmaceut Co Ltd 新規７−アミノピリド〔２，３−ｄ〕ピリミジン誘導体
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
HU229439B1 (hu) 1999-08-21 2013-12-30 Takeda Gmbh Roflumilast és salmeterol szinergetikus kombinációja
TWI243055B (en) 2000-04-13 2005-11-11 Nippon Zoki Pharmaceutical Co Pharmaceutical composition for use in treatment of dermatitis
US6825180B2 (en) * 2001-05-18 2004-11-30 Cell Therapeutics, Inc. Pyridopyrimidine compounds and their uses
IL161661A0 (en) * 2001-11-01 2004-09-27 Janssen Pharmaceutica Nv Amide derivatives as glycogen synthase kinase 3-beta inhibitors
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
TW200726767A (en) * 2005-07-04 2007-07-16 Astrazeneca Ab Chemical compounds 2
TW200800997A (en) * 2006-03-22 2008-01-01 Astrazeneca Ab Chemical compounds
PT2074122E (pt) * 2006-09-15 2011-08-24 Pfizer Prod Inc Compostos de pirido(2,3-d)-pirimidinona e sua utilização como inibidores de pi3
WO2008084236A1 (en) * 2007-01-11 2008-07-17 Astrazeneca Ab Chemical compounds 635 : pyridopyrimidinediones as pde4 inhibitors
TW200835497A (en) * 2007-01-11 2008-09-01 Astrazeneca Ab Chemical compounds 636
SA08280783B1 (ar) * 2007-01-11 2011-04-24 استرازينيكا ايه بي مشتقات بيريدوبيريميدين كمثبطات pde4
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
FR2921926B1 (fr) * 2007-10-03 2009-12-04 Sanofi Aventis Derives de quinazolinedione,leur preparation et leurs applications therapeutiques.
RU2509077C2 (ru) 2008-05-27 2014-03-10 Астразенека Аб Феноксипиридиниламидные производные и их применение в лечении pde4-опосредованных болезненных состояний
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
FR2944282B1 (fr) 2009-04-09 2013-05-03 Sanofi Aventis Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
HK1218629A1 (zh) 2013-02-25 2017-03-03 Bausch Health Ireland Limited 用於结肠清洁的鸟苷酸环化酶受体激动剂
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
MX375926B (es) 2013-08-09 2025-03-07 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
US20240400560A1 (en) * 2021-09-17 2024-12-05 Shionogi & Co., Ltd. Bicyclic heterocyclic derivative having viral growth inhibitory activity and pharmaceutical composition containing same
CN113831491B (zh) * 2021-09-30 2023-03-24 南昌大学 一种嘧啶唑共价有机框架的制备方法及吸附应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5649917B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-12-18 1981-11-25
DE2523730A1 (de) * 1974-06-12 1976-02-12 Hisamitsu Pharmaceutical Co Pyrido eckige klammer auf 2,3-d eckige klammer zu pyrimidinonen
JPS58428B2 (ja) * 1974-07-05 1983-01-06 ヒサミツセイヤク カブシキガイシヤ シンキナ ２− オキソ −１，２，３，４− テトラヒドロピリド （ ２，３−ｄ ） ピリミジンユウドウタイノ セイゾウホウ
EP0260817B1 (en) * 1986-08-21 1991-05-15 Pfizer Inc. Quinazolinediones and pyridopyrimidinediones
JPH07506369A (ja) * 1992-04-29 1995-07-13 エス・アール・アイ・インターナシヨナル 炎症を処置するためのデアザアミノプテリン

Also Published As

Publication number Publication date
JP3241384B2 (ja) 2001-12-25
CN1040327C (zh) 1998-10-21
FI944305L (fi) 1994-09-16
FI944305A0 (fi) 1994-09-16
EP0631580A1 (en) 1995-01-04
HU210873A9 (en) 1995-08-28
US5264437A (en) 1993-11-23
CN1078470A (zh) 1993-11-17
HU9402653D0 (en) 1994-11-28
NO943456L (no) 1994-09-16
MX9301530A (es) 1994-01-31
TW240226B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-02-11
KR950700909A (ko) 1995-02-20
KR100274104B1 (ko) 2000-12-15
IL105092A (en) 1998-06-15
ZA931945B (en) 1994-09-18
NZ251525A (en) 1996-09-25
HUT67552A (en) 1995-04-28
AU3918693A (en) 1993-10-21
JPH07504676A (ja) 1995-05-25
CA2132297A1 (en) 1993-09-30
FI106960B (fi) 2001-05-15
IL105092A0 (en) 1993-07-08
WO1993019068A1 (en) 1993-09-30
AU669520B2 (en) 1996-06-13
NO943456D0 (no) 1994-09-16
CA2132297C (en) 2006-01-03
EP1770093A1 (en) 2007-04-04

Similar Documents

Publication Publication Date Title
NO301763B1 (no) Eventuelt substituerte pyrido-[2,3-d]-pyrimidin-2,4-(1H,3H)-dioner og pyrido-[2,3-d]pyrimidin-2-(1H,3H)-oner, anvendelse av slike for fremstilling av legemidler, samt farmasöytiske preparater inneholdende slike
DE69231522D1 (de) 1-substituierte-4-amino-1h-imidazo 4,5-c chinoline, zwischenprodukte und arzneimittel
PL301483A1 (en) Novel derivatives of imidazopyridine, method of obtaining them as well as pharmaceutical preparation and method of obtaining same
NO995006L (no) Nye forbindelser
HUP9801587A3 (en) 5h-thiazolo[3,2-a]pyrimidine derivatives, process for their preparation, intermediates, use of the compounds and pharmaceutical compositions containing them
HUP9601240A1 (en) Pyridin and pyrimidin derivatives, suitable as beta-adrenerg agonists, pharmaceutical compositions containing the same and their intermediates
NO307091B1 (no) Nye pyrido[3,2-e]pyrazinoner, legemiddel inneholdende samme, samt anvendelse av samme for fremstilling av legemiddel
FI913477L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten imidatsoli-fenyyli-imidatso/1,2-a/pyridiini- ja imidatsoli-fenyyli-imidatso/1,2-a/pyrimidiinijohdannaisten valmistamiseksi
HUP0002902A3 (en) 3-substituted 3,4 dyhydro-thieno[2,3-d]pyrimidine derivatives and their use for the preparation of pharmaceutical compositions
AU7588696A (en) Pyrido{2, 3-D} pyrimidine derivatives and pharmaceutical compositions thereof
FI981709L (fi) Menetelmä 5-substituoitujen 2-amino-4-okso-pyrrolo/2,3-d/-pyrimidiinien valmistamiseksi
HUP9903492A3 (en) Quinoline derivatives as type iv phosphodiesterase inhibitors, process for their preparation, pharmaceutical compositions containing the same and their use
FI944933A0 (fi) 7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sitä sisältäviä farmaseuttisia käyttöjä ja koostumuksia
NZ220871A (en) 5,6,7,8-tetrahydropyrido(2,3-d)pyrimidine derivatives and pharmaceutical compositions
PT74652A (fr) Procede de preparation de derives d'imidazo <1,2-a> pyrimidines et de compositions pharmaceutiques les contenant
IL106549A0 (en) Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them
HUP0002736A3 (en) 3-substituted pyrido [3',4':4,5]thieno[2,3-d]pyrimidine derivatives, and their use for the preparation of pharmaceutical compositions
PT85001A (en) Process for the preparation of 2,3-dihydro-1-(8-methyl-1,2,4-triazolo ]4,3-b" pyridazin-6-yl)-4 (1h)-pyridinone and of pharmaceutical compositions containing the same
DE4493151T1 (de) Pyrimidinderivate und Arzneimittel
FR2722786B1 (fr) Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
IL106938A0 (en) Pyrimidine derivatives and their use as herbicides
DE69517767D1 (de) IMIDAZOLYLALKYLDERIVATE VON IMIDAZO[1,5-a]INDOL-3-ON UND IHRE VERWENDUNG ALS ARZNEIMITTEL
NO920038L (no) Nye pyrrolo (2,3-d) pyrimidin-derivater, fremgangsmaate for fremstilling derav, og farmasoeytiske preparater inneholdende derivatene
ZA92895B (en) Nitrogenous bicyclic derivatives,their preparation process,the intermediates obtained,their use as medicaments and the pharmaceutical compositions containing them
GB9210489D0 (en) Heterocyclic compounds,their preparation and pharmaceutical use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees